Minneapolis-based Imris Inc. and Kalamazoo’s Stryker Corp. announced a non-exclusive collaboration between Stryker’s automatic image registration for spinal and cranial navigated procedures and Imris’ Visius CT and MRI surgical suites.
Stryker Corp. Monday announced the global commercial launch of the Universal SmartLock Hybrid maxillomandibular fixation (MMF) system.
The latest new business earned by Michigan’s technology-focused companies
Kalamazoo-based Stryker Corp. announced Thursday the global commercial launch of the new Trevo ProVue Retriever. The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise positioning within the clot and optimized clot retrieval in patients experiencing acute ischemic stroke. Previous technology only provided visibility to the edges of the device.
Stryker Corp. announced Thursday that it has launched a computer assisted surgery system, Stryker Adapt for the Gamma3 Locking Nail System.
Stryker Corp. on Tuesday announced the expansion of the recall of its Neptune surgical waste management product line to include later versions.
The Stryker Neurovascular business of Stryker Corp. announced that its Trevo Pro Retriever blood clot remover has been granted 510(k) market clearance by the United States Food and Drug Administration,
Stryker said the recall was based on reports from the field of risks of corrosion and “fretting,” corrosion made worse by abrasive wear. The company said the corrosion “may result in adverse local tissue reactions manifesting with pain and/or swelling.”
Thursday at the European Stroke Conference in Lisbon, Portugal, Stryker announced positive results of the clincal trial of Stryker’s Trevo 2, a tool for removing blood clots from the blood vessels of stroke patients.
Stryker Corp.’s Sustainability Solutions division, a leader in medical device reprocessing, Tuesday introduced Restep, the company’s pioneering deep vein thrombosis system.